Evidence map›Paper›PMID 17262171›Full record

ArticleJournal of human genetics2007

Analysis of candidate imprinted genes in PWS subjects with atypical genetics: a possible inactivating mutation in the SNURF/SNRPN minimal promoter.

Esther N Maina, Tessa Webb, Sarita Soni, Joyce Whittington, Harm Boer, David Clarke, Anthony Holland

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Genetics of pubertal timing.Best practice & research. Clinical endocrinology & metabolism · 2022
    Review
  2. Review
  3. Genetics of Prader-Willi syndrome and Prader-Will-Like syndrome.Annals of pediatric endocrinology & metabolism · 2016
    Review
  4. Long non-coding RNAs: novel targets for nervous system disease diagnosis and therapy.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2013
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Esther N MainaUniversity Department of Medical and Molecular Genetics, Birmingham Women's Hospital Edgbaston, Birmingham, B15 2TG, UK.
Tessa WebbUniversity Department of Medical and Molecular Genetics, Birmingham Women's Hospital Edgbaston, Birmingham, B15 2TG, UK.
Sarita SoniSection of Developmental Psychiatry, Department of Psychiatry, University of Cambridge, Douglas House, Trumpington Road, Cambridge, CB2 2AH, UK.
Joyce WhittingtonSection of Developmental Psychiatry, Department of Psychiatry, University of Cambridge, Douglas House, Trumpington Road, Cambridge, CB2 2AH, UK.
Harm BoerJanet Shaw Clinic, North Warwickshire NHS Trust, Warwickshire, UK.
David ClarkeLea Castle Hospital, North Warwickshire NHS Trust, Warwickshire, UK.
Anthony HollandSection of Developmental Psychiatry, Department of Psychiatry, University of Cambridge, Douglas House, Trumpington Road, Cambridge, CB2 2AH, UK. ajh1008@cam.ac.uk.
Birmingham Women's Hospital · GBUniversity of Cambridge · GBSouth Warwickshire NHS Foundation Trust · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Prader-Willi syndrome (PWS) is a neurodevelopmental disorder associated with abnormalities of chromosome 15q11q13. The majority of cases result either from a deletion approximately 4 Mb in size, affecting chromosome 15 of paternal origin or from UPD(15)mat; these account for approximately 70 and approximately 20-25% of PWS cases, respectively. In the remaining 3-5% of PWS cases where neither the deletion nor UPD is detectable, PWS is thought to be caused either by a defect in the imprinting centre resulting in a failure to reset the paternally inherited chromosome 15 derived from the paternal grandmother or, very occasionally, from a balanced translocation involving a breakpoint in 15q11q13. Nine probands with a firm clinical diagnosis of PWS but who had neither a typical deletion in the PWS region nor UPD(15)mat were investigated for inactivating mutations in 11 genes located in the PWS region, including SNURF and SNRPN, which are associated with the imprinting centre. Other genes studied for mutations included MKRN3, NDN, IPW, HBII-85, HBII-13, HBII-436, HBII-438a, PAR1 and PAR5. A possibly inactivating mutation in the SNRPN minimal promoter region was identified. No other inactivating mutations were found in the remainder of our panel of PWS subjects with atypical genetics. Expression levels of several of the candidate genes for PWS were also investigated in this series of probands. The results indicate that PWS may result from a stochastic partial inactivation of important genes.

Indexed as

Gene SilencingGenomic ImprintingAutoantigensChromosomes, Human, Pair 15DNA Mutational AnalysisGene ExpressionHumansMutationNuclear ProteinsPrader-Willi SyndromePromoter Regions, GeneticRibonucleoproteins, Small NuclearsnRNP Core ProteinsAutoantigensNuclear ProteinsRibonucleoproteins, Small NuclearsnRNP Core ProteinsSNRPN protein, humanSNURF protein, human

Identifiers

PMID17262171
OpenAlexW1968087628

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.